In a clinical trial involving women with unexplained infertility and male-factor or low male sperm count, the ITI approach achieved a pregnancy rate of 26.3% per subject and 17.5% per cycle, significantly higher than the historical 6.7% per-cycle rate with IUI in similar patient populations. Most successful pregnancies occurred after just one procedure, and the treatment demonstrated a safety profile comparable to IUI, with no new safety concerns reported. These findings suggest it may offer a more effective and less invasive alternative for couples trying to conceive and should be considered first.
Non-surgical permanent birth control represents a promising area within the Femtech landscape. While tubal occlusion has been explored through various approaches, some of which were previously approved but later withdrawn from the market, only one method remains today that has demonstrated both safety and meaningful clinical potential without the need for invasive surgery, implants, or hormones. In a clinical trial involving women seeking permanent contraception, this novel non-surgical option demonstrated a favorable safety profile, with only transient adverse events reported over a five-year period, along with compelling evidence of effectiveness. It may offer a viable solution for the estimated 13 million American women who do not wish to have children or additional children but continue to rely on temporary methods and their associated risks. A modern, non-invasive alternative to surgical sterilization is long overdue.

Ad Statistics
Times Displayed: 7986
Times Visited: 123 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
Leading the charge: How Femtech is reshaping women's health
The development of Femtech technology transforms the healthcare services that women require today. The potential scope of this segment to reshape women's healthcare appears enormous for future growth. Future technological advancements will result in minimally invasive procedures that lower healthcare expenses and expand access to care for women. For example, the future of fertility monitoring will advance through the integration of AI and real-time data systems, enabling women to have greater control over their health and family planning choices. The acceptance of minimally invasive procedures will drive more innovations in other areas, such as menopause management, hormonal health, and sexual wellness. Because women are demanding better healthcare solutions through Femtech platforms, these solutions can resolve healthcare gaps that affect women who live in neglected regions and those who struggle financially. The expansion of Femtech offers affordable reproductive healthcare options that ensure every woman obtains the medical care she needs, regardless of her socioeconomic background. Most importantly, because more than 40% of women worldwide lack access to reproductive health services, it plays a vital role in reducing service gaps.